beleodaq
(Belinostat)Acrotech Biopharma Inc
Usage: Beleodaq is indicated for treating adult patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Approval is based on tumor response rates and duration, but improvement in survival or symptoms has not been established. Continued approval may depend on further clinical benefit verification.